Healthcare, Life Sciences and Pharmaceuticals · Published Aug 2026
Veterinary Care Market
The veterinary care market is projected to expand from USD 9,721.38 million in 2025 to USD 19,666.41 million by 2035, reflecting a compound annual growth rate (CAGR) of 7.3%. Growth is driven by rising pet ownership, increased focus on preventive care, and advancements in veterinary diagnostics and telehealth technologies. The market is segmented by treatment type into No medicalization, Basic Medicalization, and Under Long Term Veterinary Care, and by animal type including Dogs, Cats, Cattle, Horses, Pigs, and Poultry.
North America leads the market, supported by robust regulatory frameworks and high pet humanization trends.
Market size
Growth trajectory through 2035
Veterinary Care Market · Market size 2025–2035
Base year 2025 · Forecast 2035 · USD Billion
Source: Exactitude Consultancy analyst modeling. Anchor values from primary + secondary research; intermediate years interpolated from the CAGR trajectory. Full annual data pack included with the report.
What's new in this edition
Here's what changed
This edition rebased the forecast to 2025, added tracked developments through the last quarter, and re-cited every numeric claim against live public sources.
Recent developments tracked
-
Development 01 Telehealth integration
- Platforms such as Airvet and Vetster expanded veterinary telehealth services, enabling remote consultations and diagnostics.
-
Development 02 Diagnostic advancements
- Companies like IDEXX and Zoetis launched new veterinary diagnostic kits, improving early disease detection in companion and livestock animals.
-
Development 03 Regulatory updates
- New animal welfare regulations in North America and Europe are driving demand for compliant veterinary services and products.
Emerging opportunities added
- Telehealth expansion Digital platforms for remote consultations and diagnostics are expected to grow, addressing access gaps in rural and underserved regions.
- Diagnostic innovation Advances in veterinary diagnostic kits enable early disease detection, reducing economic losses in livestock and companion animals.
- Regional growth in Asia-Pacific Urban pet ownership and government veterinary infrastructure programs are accelerating market expansion.
Executive snapshot
The four things that matter
A condensed view of the market at a glance — sized, shaped, and pressure-tested against live public sources.
Market size · 2025–2035
forecast for 2035
- 2025 base
- $9.72 Bn
- CAGR
- 7.30%
- Expansion
- 2.0×
Market shape
leading region
- Leading region
- North America
- Top-5 concentration
- Low to medium · ~42%
Forces at play
▲ top tailwind
- ▼ headwind
- Regulatory hurdles
- Named players
- 15 profiled
- Growth peak
- 2027–2031
Latest development
Telehealth integration: Platforms such as Airvet and Vetster expanded veterinary telehealth services, enabling remote consultations and diagnostics
+2 more tracked in this edition
Report scope
What this report answers
The specific decisions and questions covered in the 138-page report and its accompanying data pack — tailored to this market's segments, applications, and named competitors.
- How big is the Veterinary Care Market today ($9.72 Bn base), and how fast will it grow at 7.3% CAGR through 2035?
- How do North America, Europe, Asia-Pacific, Latin America, and MEA compare on market share and growth rate?
- Where do Zoetis Inc, Boehringer Ingelheim Animal Health, Merck Animal Health and 12 other named players sit in market share, tier, and product breadth?
- What are the top growth drivers (led by Rising pet ownership) and top restraints (led by Regulatory hurdles), with quantified CAGR impact?
- What regulatory shifts and 3 tracked developments (2024–2025) materially affect the forecast?
- Which segments and geographies present the strongest investment thesis given the growth-window 2027–2031?
Market dynamics
Why the number moves this way
The forces expanding this market and the ones holding it back — each broken down into distinct, scannable points.
Growth drivers
Pulling the market up
- Rising pet ownership Approximately 67% of U.S. households own a pet, driving demand for veterinary services and preventive care.
- Preventive care adoption Shift from reactive to proactive veterinary care, including wellness exams and early disease detection.
- Technological advancements Growth in veterinary telehealth, diagnostic kits, and artificial insemination technologies enhancing service accessibility and efficiency.
- Regulatory support Strengthened animal welfare regulations and standards improving service quality and trust in veterinary practices.
Restraints
Holding it back
- Regulatory hurdles Approval timelines for veterinary pharmaceuticals and devices may extend by 6-12 months post-2025.
- Supply chain constraints Component shortages for veterinary instruments and diagnostics persisted through H1 2025.
- High operational costs Veterinary clinics face rising costs of specialized equipment and skilled labor, impacting affordability.
Trends
What we're watching
- Consolidation activity is accelerating as top players seek scale advantages; the report tracks named M&A + partnerships quarterly.
- Sustainability and traceability requirements are reshaping procurement criteria across enterprise buyers.
Impact analysis
Quantified drivers & restraints
Percentages are directional contributions to overall CAGR — not additive. Full sensitivity tables in the sample.
| Driver | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Rising pet ownership | +3.3% | Global | 2025–2035 |
| Preventive care adoption | +2.0% | Global | 2025–2035 |
| Technological advancements | +1.6% | Global | 2025–2035 |
| Regulatory support | +1.1% | Global | 2025–2035 |
Restraints impact analysis
| Restraint | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Regulatory hurdles | −1.3% | Global | 2025–2029 |
| Supply chain constraints | −0.9% | Global | 2025–2029 |
| High operational costs | −0.7% | Global | 2025–2029 |
The veterinary care market is segmented by treatment type into No medicalization, Basic Medicalization, and Under Long Term Veterinary Care. By animal type, the market includes Dogs, Cats, Cattle, Horses, Pigs, and Poultry. Companion animals (dogs and cats) dominate the market, while livestock segments reflect regional agricultural priorities.
Geography
Regional market share
Base-year (2025) share by region. Growth rates through 2035 vary widely by market maturity — country-level detail sits in the report.
Regional share · 2025
SHARE OF $9.72 BN BASE MARKET
Bars sized to relative regional share. Leader region highlighted in gold.
North America leads regional demand at ~42.8% in 2025. Driven by manufacturing scale and end-market density.
Competitive landscape
Who's competing, and how
The market is Low to Medium concentration. 15 named players are profiled in the report with product portfolios, financials where public, and recent strategic moves.
The veterinary care market is consolidated among global pharmaceutical and animal health firms, including Pfizer, Johnson & Johnson, Merck, Novartis, Roche, AbbVie, Eli Lilly, AstraZeneca, GSK, and GlaxoSmithKline. Key players focus on product innovation, strategic partnerships, and regional expansion to strengthen market presence.
Concentration snapshot
Top 5 players control ~35–50% of the market
Estimated aggregate share of the top 5 by 2025 revenue. Named breakdown + individual shares in the full report.
Competitive tiers
Players are grouped into three tiers by revenue rank, product breadth, and strategic footprint. Full tier assignment in the report.
Tier 1 · Leaders
3companies
Global scale, integrated portfolio, brand recognition. Setting the pricing benchmark.
Tier 2 · Challengers
5companies
Regional strongholds, focused portfolio, actively expanding via M&A or capacity.
Tier 3 · Emerging
7companies
Niche or early-stage, differentiated technology or early-mover positioning.
Named players covered
Every profiled company includes market rank, base-year share, revenue estimate, HQ, product portfolio depth, and recent strategic moves. Unlock in the sample.
-
Zoetis Inc
Rank 01Share est. ~16%Revenue $■■■MHQ ■■■ -
Boehringer Ingelheim Animal Health
Rank 02Share ■■.■%Revenue $■■■MHQ ■■■ -
Merck Animal Health
Rank 03Share ■■.■%Revenue $■■■MHQ ■■■ -
Elanco Animal Health
Rank 04Share ■■.■%Revenue $■■■MHQ ■■■ -
Ceva Sante Animale
Rank 05Share ■■.■%Revenue $■■■MHQ ■■■ -
Virbac SA
Rank 06Share ■■.■%Revenue $■■■MHQ ■■■ -
Vetoquinol SA
Rank 07Share ■■.■%Revenue $■■■MHQ ■■■ -
IDEXX Laboratories
Rank 08Share ■■.■%Revenue $■■■MHQ ■■■
+ 7 more player profiles in the full report.
Unlock the full competitive landscape
Per-player market share, revenue estimates, HQ, product portfolio depth, recent M&A + partnerships, and 3-tier ranking rationale — sample included.
Regulatory landscape
Policy and standards affecting the forecast
Material regulatory shifts across the major regional markets. The report tracks these quarter-by-quarter and quantifies their forecast impact.
-
United States
FDA CDER/CBER approves new drugs and biologics; typical NDA review 10 months (standard), 6 months (priority). IRA drug price negotiation covers first 10 Medicare Part D drugs 2026, expanding annually. CMS coverage decisions gate market access. State-level PBM reform + 340B changes reshape distribution.
-
European Union
EMA centralised procedure mandatory for biotech, oncology, HIV, orphan drugs — 210-day evaluation timeline. HTA Regulation (EU 2021/2282) unifies clinical assessment across member states from 2025. Joint clinical assessment for cancer + advanced therapies 2025, orphans 2028. GDPR + national health data laws govern secondary use of clinical data.
-
China / APAC
NMPA reform since 2015 reduced approval times from 5+ years to ~14 months; ICH-aligned data acceptance. Volume-based procurement (VBP) rounds 1-11 have negotiated pricing for 500+ drugs (avg 50-80% reduction). National Reimbursement Drug List (NRDL) annual negotiation determines Chinese market access.
-
Global standards
ICH (International Council for Harmonisation) guidelines adopted by FDA, EMA, PMDA, NMPA, Health Canada, and Swissmedic. WHO Prequalification enables procurement by UN agencies and major donors. USP, EP, JP pharmacopoeia standards govern drug quality worldwide. GxP quality standards (GCP, GMP, GLP, GVP) universal.
Purchase options
License this report
All licenses include the full PDF report + Excel data pack + one analyst clarification call. Choose based on how many colleagues will need access.
Single user
$3,499
- 1 named user, non-transferable
- Full PDF + Excel data pack
- 1 hour analyst clarification call
Multi user
$4,499
- Up to 5 users at one location
- Full PDF + Excel data pack
- 2 hours analyst time
- Priority email support
Corporate
$5,499
- Unlimited users org-wide
- Full PDF + Excel data pack
- 4 hours analyst time
- Presentation-ready deck
Need custom scope, region cuts, or country-level detail? Request customization or speak to an analyst.
How buying works
- 01 Select a license — your enquiry reaches the desk lead within one business day.
- 02 Invoice issued — pay by wire transfer, corporate PO, or online (PayPal / Razorpay / cards). Preferred by most procurement teams.
- 03 Report delivered — full PDF + Excel data pack + analyst call slot in your inbox on receipt of payment.
Payment methods accepted
- PayPalGlobal
- RazorpayCards · UPI · Netbanking
- Visa · Mastercard · AmexVia gateway
- Wire transferUSD · EUR · INR · GBP
- Corporate PONet-30 on approval
Invoices raised in your billing currency. Enterprise procurement docs (W-9 / W-8BEN / VAT registration) available on request.
Methodology
How we built this estimate
Every number in this report is derived from three converging paths — primary interviews, top-down macro sizing, and bottom-up named-company revenue build-up — and re-verified against live public sources at each edition refresh.
-
Primary research
Structured analyst interviews with buyers, vendors, and distributors across the value chain — top-tier OEMs, mid-market integrators, and specialised suppliers. Respondent distribution is disclosed in the sample so readers can weight the mix themselves.
-
Secondary research
Company filings, trade association reports, government statistics, and paid databases feed the top-down macro layer. Every source is footnoted in the report so any downstream reader can retrace how a number was arrived at.
-
Data triangulation
Three independent estimation paths — top-down macro sizing, bottom-up named-company build-up, and cross-check against installed-base or shipment proxies — converge to a single defensible number. Divergences greater than 8% trigger a re-review.
-
Analyst review
Every model is pressure-tested by a senior analyst before publication. Assumptions are stated explicitly, sensitivities are documented, and the accompanying Excel data pack lets clients replicate every calculation on their own inputs.
Frequently asked questions
Common questions about this report
-
● What is the worth of the global veterinary care market?
The Veterinary care market size has crossed USD 5.9 billion in 2020 and will observe a CAGR of more than 7.3% up to 2027 driven by the rising technological advancements in care processes. -
● What is the size of the North America veterinary care industry?
North America held more than 38% of the veterinary care market revenue share in 2020 and will witness expansion with the surging demand for veterinary care in countries, including U.S. and Canada. -
● What are the upcoming trends of the veterinary care market, globally?
The upcoming trends in the veterinary care market are expansion in the technological advancements in veterinary care will drive industry revenue in the next few years -
● What is the CAGR of theveterinary care market?
The global veterinary care market registered a CAGR of 7.3% from 2022 to 2029. The application segment was the highest revenue contributor to the market, with 5.9 billion in 2020, and is estimated to reach 11.2 million by 2029, with a CAGR of 8%. -
● Which are the top companies to hold the market share in theveterinary care market?
Key players profiled in the report include Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), Virbac SA (France), IDEXX Laboratories, Inc., Neogen Corporation (US), Heska Corporation (US) and others. -
● What is the leading application of the veterinary care market?
The Basic medicalization market segment type dominated the market. -
● Which is the largest regional market for veterinary care market?
North America is the largest regional market for veterinary care.
The Veterinary Care Market is projected to reach $19.66 Bn by 2035, up from $9.72 Bn in 2025 — a 7.30% CAGR equating to roughly 2.0× expansion. The bars anchor both endpoints so you can pressure-test the trajectory against your own assumptions.